Skip to main content
Caplight Logo









Deliberate AI

Deliberate AI

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.deliberate.ai/

Last Round

Seed

Jun 11, 2026

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Deliberate AI is a healthcare technology company that develops regulatory-grade, precision measurement technology for mental and neurological health care using multimodal artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Clinical Trials, Computer Vision, Mental Health, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

clinical AIcomputer visionbehavioral healthclinical trialsdigital biomarkersmental health techhealth techclinical assessmentmultimodal AIpatient monitoringAI-COAclinical outcome assessmentbiomarker discoverymedtechhealthcare analytics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deliberate AI Comparables

Compare Deliberate AI with similar companies based on industry and business-model similarity.

Deliberate AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Storyline Health
84%
Altoida, Inc.
80%
AiCure
78%

Deliberate AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJun 11, 2026
AcceleratorFeb 21, 2025
AcceleratorMar 21, 2022

Key People

Founding team and executive leadership

Marc Aafjes

Founder & CEO

Founding Team

Deliberate AI Investors

Notable investors and investment history

Deliberate AI investors
InvestorRounds
Scribble VenturesSeed
PharmStarsAccelerator
One MindAccelerator
Bessemer Venture PartnersSeed
Kleiner PerkinsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 15, 2026

    Grew 63% QoQ from 8 to 13 employees.

  • Jul 29, 2026

    Grew 50% QoQ from 8 to 12 employees.

Deliberate AI Filings

Explore SEC and related filing metadata, where available.

Deliberate AI filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Deliberate AI's valuation, stock price, and market status.

Is Deliberate AI a public or private company?

Deliberate AI is a private company.

What is the current stock price of Deliberate AI?

Deliberate AI is a private company with no public stock price. No recent secondary market data is available.

How much is Deliberate AI worth (valuation)?

Valuation information for Deliberate AI is not publicly available.

Can I buy Deliberate AI stock?

Deliberate AI shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Deliberate AI's last funding round?

Deliberate AI's most recent funding round was Accelerator on February 21, 2025.

Who are the main investors in Deliberate AI?

Key investors in Deliberate AI include PharmStars, One Mind.

Will Deliberate AI IPO soon?

No public IPO plans have been announced for Deliberate AI.

How can I track Deliberate AI secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Deliberate AI's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range12
Year Founded2020
Last FundingJun 11, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?